68Ga-PSMA-11 PET in Patients With Prostate Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

September 29, 2021

Primary Completion Date

April 14, 2022

Study Completion Date

April 14, 2022

Conditions
Prostate CancerProstate Adenocarcinoma
Interventions
DRUG

Ga-PSMA-11

The PSMA Sterile Cold Kit, is a kit comprising all needed materials (lyophilized PSMA for PSMA reconstitution, elution vial for Ga and ancillary materials for transfer between vials) to perform a room-temperature radiolabelling of PSMA-11 with Ga. Ga is not part of the kit and should be provided in the form gallium chloride solution following the requirements of the relevant local regulations. PSMA-11 radiolabelled with Ga is administered in patients with prostate cancer recurrence after radical treatment.

Trial Locations (2)

80045

Colorado Research Center, Aurora

80217-3364

UCHealth-Metro Denver, Denver

All Listed Sponsors
lead

University of Colorado, Denver

OTHER

NCT05197257 - 68Ga-PSMA-11 PET in Patients With Prostate Cancer | Biotech Hunter | Biotech Hunter